UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 63

Sortiert nach

Extracellular and Intracellular Magnesium Deficiency Found in Pregnant Women with Preeclampsia and Gestational Diabetes Is Associated with Overexpression of Notch Proteins, Cytokines, p53, NF-kB and Proto-Oncogenes: Potential Importance in Growth Retardation, Stillbirths, Fetal Mutations and Increased Cardiovascular Risks and Stroke with Advancing Age in Pregnant Women

Hearts (Basel, Switzerland), 2021-03, Vol.2 (1), p.139-148

2021

Volltextzugriff (PDF)

Process optimization for continuous extrusion wet granulation

Pharmaceutical development and technology, 2011-08, Vol.16 (4), p.302-315

2011

Volltextzugriff (PDF)

Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)

Bioorganic & medicinal chemistry, 2008-01, Vol.18 (2), p.554-559

2008

Volltextzugriff (PDF)

Improving the Content Uniformity of a Low-Dose Tablet Formulation Through Roller Compaction Optimization

Pharmaceutical development and technology, 2007-01, Vol.12 (4), p.391-404

2007

Volltextzugriff (PDF)

Statistics in Pharmaceutical Development and Manufacturing

Journal of quality technology, 2009-04, Vol.41 (2), p.111-134

2009

Volltextzugriff (PDF)

Vectored Gag and Env but Not Tat Show Efficacy against Simian-Human Immunodeficiency Virus 89.6P Challenge in Mamu-A01-Negative Rhesus Monkeys

Journal of Virology, 2005-10, Vol.79 (19), p.12321-12331

2005

Volltextzugriff (PDF)

HDFx: a novel biologic immunomodulator accelerates wound healing and is suggestive of unique regenerative powers: potential implications for the warfighter and disaster victims

International journal of clinical and experimental medicine, 2012-01, Vol.5 (4), p.289-295

2012

Volltextzugriff (PDF)

HDFx: a novel biologic immunomodulator is therapeutically -effective in hemorrhagic and intestinal-ischemic shock: importance of microcirculatory-immunological interactions and their potential implications for the warfighter and disaster victims

International journal of clinical and experimental medicine, 2011-01, Vol.4 (4), p.331-340

2011

Volltextzugriff (PDF)

A novel biologic immunomodulator, HDFx, protects against lethal hemorrhage, endotoxins and traumatic injury: potential relevance to emerging diseases

International journal of clinical and experimental medicine, 2009-09, Vol.2 (3), p.266-279

2009

Volltextzugriff (PDF)

Impact of security awareness training on phishing click-through rates

2017 IEEE International Conference on Big Data (Big Data), 2017, p.4458-4466

2017

Volltextzugriff (PDF)

Rejoinder

Journal of quality technology, 2009-04, Vol.41 (2), p.145-147

2009

Volltextzugriff (PDF)

Rejoinder

Journal of quality technology, 2009-04, Vol.41 (2), p.145-147

2009

Volltextzugriff (PDF)

Corrigendum to “Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)” [Bioorg. Med. Chem. Lett. (2008) 554]

Bioorganic & medicinal chemistry letters, 2010-09, Vol.20 (17), p.5360-5360

2010

Volltextzugriff (PDF)

Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 1: Discovery and initial structure-activity relationships for 1-amino-2-phenyl-4-(piperidin-1-yl)butanes

Bioorganic & medicinal chemistry letters, 2001-01, Vol.11 (2), p.259-264

2001

Volltextzugriff (PDF)

Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 2: Structure-activity relationships for substituted 2-aryl-1-[N-(methyl)-N-(phenylsulfonyl)amino]-4-(piperidin-1-yl)butanes

Bioorganic & medicinal chemistry letters, 2001-01, Vol.11 (2), p.265-270

2001

Volltextzugriff (PDF)

Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 2: Discovery of potent, selective, and orally bioavailable compounds

Bioorganic & medicinal chemistry letters, 2004-02, Vol.14 (4), p.941-945

2004

Volltextzugriff (PDF)

1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 2: lead optimization affording selective, orally bioavailable compounds with potent Anti-HIV activity

Bioorganic & medicinal chemistry letters, 2001-10, Vol.11 (20), p.2741-2745

2001

Volltextzugriff (PDF)

Synthesis and evaluation of CCR5 antagonists containing modified 4-piperidinyl-2-phenyl-1-(phenylsulfonylamino)-butane

Bioorganic & medicinal chemistry letters, 2005-02, Vol.15 (4), p.977-982

2005

Volltextzugriff (PDF)

Combinatorial synthesis of CCR5 antagonists

Bioorganic & medicinal chemistry letters, 2001-12, Vol.11 (24), p.3137-3141

2001

Volltextzugriff (PDF)

Statistics in Pharmaceutical Development and Manufacturing/Discussion/Discussion/Discussion/Discussion/Rejoinder

Journal of quality technology, 2009-04, Vol.41 (2), p.111-147

2009

Volltextzugriff (PDF)

Design, synthesis, and SAR of heterocycle-containing antagonists of the human CCR5 receptor for the treatment of HIV-1 infection

Bioorganic & medicinal chemistry letters, 2001-12, Vol.11 (24), p.3103-3106

2001

Volltextzugriff (PDF)

Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 3: SAR studies on the benzylpyrazole segment

Bioorganic & medicinal chemistry letters, 2004-02, Vol.14 (4), p.947-952

2004

Volltextzugriff (PDF)

1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 4: Synthesis of N-1 acidic functionality affording analogues with enhanced antiviral activity against HIV

Bioorganic & medicinal chemistry letters, 2002-10, Vol.12 (20), p.3001-3004

2002

Volltextzugriff (PDF)

Statistics in Pharmaceutical Development and Manufacturing. Discussion

Journal of quality technology, 2009, Vol.41 (2), p.111-147

2009

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(61)

Publikationsform

Sprache

Englisch
(63)

Erscheinungsjahr

n.n

Thema

Science & Technology
(45)
Life Sciences & Biomedicine
(38)
Biological And Medical Sciences
(28)
Pharmacology & Pharmacy
(24)
Medical Sciences
(23)
Physical Sciences
(23)
Chemistry
(22)
Pharmacology. Drug Treatments
(22)
Humans
(20)
Animals
(18)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(18)
Chemistry, Organic
(18)
Antiviral Agents
(17)
Chemistry, Medicinal
(17)
Ccr5 Receptor Antagonists
(15)
Anti-Hiv Agents - Chemical Synthesis
(14)
Structure-Activity Relationship
(14)
Rats
(11)
Anti-Hiv Agents - Pharmacology
(10)
Male
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Process optimization for continuous extrusion wet granulation

Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)

Improving the Content Uniformity of a Low-Dose Tablet Formulation Through Roller Compaction Optimization

Attenuation of Simian Immunodeficiency Virus SIVmac239 Infection by Prophylactic Immunization with DNA and Recombinant Adenoviral Vaccine Vectors Expressing Gag

Statistics in Pharmaceutical Development and Manufacturing

Vectored Gag and Env but Not Tat Show Efficacy against Simian-Human Immunodeficiency Virus 89.6P Challenge in Mamu-A01-Negative Rhesus Monkeys

HDFx: a novel biologic immunomodulator accelerates wound healing and is suggestive of unique regenerative powers: potential implications for the warfighter and disaster victims

HDFx: a novel biologic immunomodulator is therapeutically -effective in hemorrhagic and intestinal-ischemic shock: importance of microcirculatory-immunological interactions and their potential implications for the warfighter and disaster victims

A novel biologic immunomodulator, HDFx, protects against lethal hemorrhage, endotoxins and traumatic injury: potential relevance to emerging diseases

Impact of security awareness training on phishing click-through rates

Rejoinder

Rejoinder

Corrigendum to “Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)” [Bioorg. Med. Chem. Lett. (2008) 554]

Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 1: Discovery and initial structure-activity relationships for 1-amino-2-phenyl-4-(piperidin-1-yl)butanes

Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 2: Structure-activity relationships for substituted 2-aryl-1-[N-(methyl)-N-(phenylsulfonyl)amino]-4-(piperidin-1-yl)butanes

Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 2: Discovery of potent, selective, and orally bioavailable compounds

1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 2: lead optimization affording selective, orally bioavailable compounds with potent Anti-HIV activity

Synthesis and evaluation of CCR5 antagonists containing modified 4-piperidinyl-2-phenyl-1-(phenylsulfonylamino)-butane

Combinatorial synthesis of CCR5 antagonists

Statistics in Pharmaceutical Development and Manufacturing/Discussion/Discussion/Discussion/Discussion/Rejoinder

Design, synthesis, and SAR of heterocycle-containing antagonists of the human CCR5 receptor for the treatment of HIV-1 infection

Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 3: SAR studies on the benzylpyrazole segment

1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 4: Synthesis of N-1 acidic functionality affording analogues with enhanced antiviral activity against HIV

Statistics in Pharmaceutical Development and Manufacturing. Discussion

Aktive Filter

Suchergebnisse filtern